In this issue:
- Silicosis in US engineered stone countertop fabrication workers
- Association of statin use with ILD/IPF risk
- Pirfenidone in RA-associated ILD
- Rituximab vs. cyclophosphamide in CTD-associated ILD
- Rituximab + mycophenolate mofetil in ILD
- Treatment outcomes for RA-associated ILD
- Incidence of interstitial lung abnormalities
- Association of PM2.5 exposure with lung function and mortality in fibrotic ILD
- Trends in US hospitalisations and inpatient mortality for pulmonary sarcoidosis
- Palliative care for ILD
Please login below to download this issue (PDF)